A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

George D. Dangas; Jan G.P. Tijssen; Jochen Wöhrle; Lars Søndergaard; Martine Gilard; Helge Möllmann; Raj R. Makkar; Howard C. Herrmann; Gennaro Giustino; Stephan Baldus; Ole de Backer; Ana H.C. Guimarães; Lars Gullestad; Annapoorna Kini; Dirk von Lewinski; Michael Mack; Raúl Moreno; Ulrich Schäfer; Julia Seeger; Didier Tchétché; Karen Thomitzek; Marco Valgimigli; Pascal Vranckx; Robert C. Welsh; Peter Wildgoose; Albert A. Volkl; Ana Zazula; Ronald G.M. van Amsterdam; Roxana Mehran; Stephan Windecker; GALILEO Investigators

doi:10.1056/NEJMoa1911425

A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

George D. Dangas
, Jan G.P. Tijssen
, Jochen Wöhrle
, Lars Søndergaard
, Martine Gilard
, Helge Möllmann
, Raj R. Makkar
, Howard C. Herrmann
, Gennaro Giustino
, Stephan Baldus
, Ole de Backer
, Ana H.C. Guimarães
, Lars Gullestad
, Annapoorna Kini
, Dirk von Lewinski
, Michael Mack
, Raúl Moreno
, Ulrich Schäfer
, Julia Seeger
, Didier Tchétché

Karen Thomitzek, Marco Valgimigli, Pascal Vranckx, Robert C. Welsh, Peter Wildgoose, Albert A. Volkl, Ana Zazula, Ronald G.M. van Amsterdam, Roxana Mehran, Stephan Windecker^*, GALILEO Investigators

^*Corresponding author for this work

Department of Internal Medicine 1 - Cardiology and Internal Critical Care

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	120-129
Number of pages	10
Journal	New England Journal of Medicine
Volume	382
Issue number	2
DOIs	https://doi.org/10.1056/NEJMoa1911425
Publication status	Published - 09 Jan 2020

Fields of science

302031 Intensive care medicine
302032 Cardiology
302030 Internal medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMoa1911425

Cite this

Dangas, G. D., Tijssen, J. G. P., Wöhrle, J., Søndergaard, L., Gilard, M., Möllmann, H., Makkar, R. R., Herrmann, H. C., Giustino, G., Baldus, S., de Backer, O., Guimarães, A. H. C., Gullestad, L., Kini, A., von Lewinski, D., Mack, M., Moreno, R., Schäfer, U., Seeger, J., ... GALILEO Investigators (2020). A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. New England Journal of Medicine, 382(2), 120-129. https://doi.org/10.1056/NEJMoa1911425

@article{2bdf9fe4c1634ed695eb9acc85c8094c,

title = "A controlled trial of rivaroxaban after transcatheter aortic-valve replacement",

author = "Dangas, \{George D.\} and Tijssen, \{Jan G.P.\} and Jochen W{\"o}hrle and Lars S{\o}ndergaard and Martine Gilard and Helge M{\"o}llmann and Makkar, \{Raj R.\} and Herrmann, \{Howard C.\} and Gennaro Giustino and Stephan Baldus and \{de Backer\}, Ole and Guimar{\~a}es, \{Ana H.C.\} and Lars Gullestad and Annapoorna Kini and \{von Lewinski\}, Dirk and Michael Mack and Ra{\'u}l Moreno and Ulrich Sch{\"a}fer and Julia Seeger and Didier Tch{\'e}tch{\'e} and Karen Thomitzek and Marco Valgimigli and Pascal Vranckx and Welsh, \{Robert C.\} and Peter Wildgoose and Volkl, \{Albert A.\} and Ana Zazula and \{van Amsterdam\}, \{Ronald G.M.\} and Roxana Mehran and Stephan Windecker and \{GALILEO Investigators\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2019 Massachusetts Medical Society.",

year = "2020",

month = jan,

day = "9",

doi = "10.1056/NEJMoa1911425",

language = "English",

volume = "382",

pages = "120--129",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "2",

}

Dangas, GD, Tijssen, JGP, Wöhrle, J, Søndergaard, L, Gilard, M, Möllmann, H, Makkar, RR, Herrmann, HC, Giustino, G, Baldus, S, de Backer, O, Guimarães, AHC, Gullestad, L, Kini, A, von Lewinski, D, Mack, M, Moreno, R, Schäfer, U, Seeger, J, Tchétché, D, Thomitzek, K, Valgimigli, M, Vranckx, P, Welsh, RC, Wildgoose, P, Volkl, AA, Zazula, A, van Amsterdam, RGM, Mehran, R, Windecker, S & GALILEO Investigators 2020, 'A controlled trial of rivaroxaban after transcatheter aortic-valve replacement', New England Journal of Medicine, vol. 382, no. 2, pp. 120-129. https://doi.org/10.1056/NEJMoa1911425

TY - JOUR

T1 - A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

AU - Dangas, George D.

AU - Tijssen, Jan G.P.

AU - Wöhrle, Jochen

AU - Søndergaard, Lars

AU - Gilard, Martine

AU - Möllmann, Helge

AU - Makkar, Raj R.

AU - Herrmann, Howard C.

AU - Giustino, Gennaro

AU - Baldus, Stephan

AU - de Backer, Ole

AU - Guimarães, Ana H.C.

AU - Gullestad, Lars

AU - Kini, Annapoorna

AU - von Lewinski, Dirk

AU - Mack, Michael

AU - Moreno, Raúl

AU - Schäfer, Ulrich

AU - Seeger, Julia

AU - Tchétché, Didier

AU - Thomitzek, Karen

AU - Valgimigli, Marco

AU - Vranckx, Pascal

AU - Welsh, Robert C.

AU - Wildgoose, Peter

AU - Volkl, Albert A.

AU - Zazula, Ana

AU - van Amsterdam, Ronald G.M.

AU - Mehran, Roxana

AU - Windecker, Stephan

AU - GALILEO Investigators

PY - 2020/1/9

Y1 - 2020/1/9

UR - https://www.scopus.com/pages/publications/85075993796

U2 - 10.1056/NEJMoa1911425

DO - 10.1056/NEJMoa1911425

M3 - Article

C2 - 31733180

AN - SCOPUS:85075993796

SN - 0028-4793

VL - 382

SP - 120

EP - 129

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -

A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this